❭ Research by medical division ❭ Cancer Medicine ❭ Institute for Cancer Research ❭ Dept. of Tumor Biology ❭ News

News

Scroll to top

Home Institute for Cancer Research Dept. of Tumor Biology

  • Resources and expertise
  • Cancer Systems Biomedicine [Clancy)
  • Translational Cancer Therapy [Flatmark]
  • Metastasis Biology and Experimental Therapeutics [Mælandsmo]
  • Molecular Biology of Sarcomas [Wesche]
  • Project groups Tumor Biology
  • Publications
  • Staff
  • Vacant positions
  • News

Recent publications

Kohut K, Kuti JA, Balladares S, Reents N, Sayyed R, Mauro Rossi B, Balazar-Palacios J, Adenipekun B, Battisti NML, László Dégi C, Dominguez-Valentin M (2026)
Aligning awareness, systems and policy to increase equitable access to genomically driven cancer care
BMJ Oncol, 5 (2), e000856
DOI 10.1136/bmjonc-2025-000856, PubMed 42688961

Sivanesan S, Ramberg H, Kristiansen T, Thapa SB, Bjøre M, Berge V, Ottosson F, Brennhovd B, Storås AMH, Thorsby PM, Dahl SR, Urbanucci A, Grytli HH, Bjerke L, Taskén KA (2026)
Perioperative propranolol during robotic-assisted radical prostatectomy: A randomised, double-blind, placebo-controlled, pilot trial (PeP-RALP)
BJUI Compass, 7 (9), e70267
DOI 10.1002/bco2.70267, PubMed 42662047

Officer A, Lindeman I, Pavlovic M, Lund-Andersen C, Ness-Jensen E, Sandve GK, Sollid LM (2026)
Naïve adaptive immune receptor repertoires in celiac disease assessed by machine learning; impact of the HLA-DQ2.5 allotype on the TCR repertoire
Immunogenetics, 78 (1)
DOI 10.1007/s00251-026-01412-3, PubMed 42649420

More publications

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Cookie policy

Accessibility statement (in Norwegian)